Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report

British Journal of Oral and Maxillofacial Surgery

Volumn 47, Issue 1, 2009, Pages 59-61

  de Lange, Jan ^a   van Rijn, Rick R ^b   van den Berg, Henk ^b   van den Akker, Hans P ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Calcitonin; Central giant cell granuloma; Imatinib; Interferon alpha; Stickler syndrome

Indexed keywords

CALCITONIN; CORTICOSTEROID; IMATINIB; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GIANT CELL GRANULOMA; HUMAN; HUMAN TISSUE; LEUKOPENIA; MANDIBLE TUMOR; SKIN BIOPSY; STICKLER SYNDROME; TREATMENT DURATION; TUMOR REGRESSION; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CALCITONIN; COLLAGEN DISEASES; DRUG COMBINATIONS; FEMALE; GRANULOMA, GIANT CELL; HUMANS; INTERFERON ALFA-2A; MANDIBULAR DISEASES; PIPERAZINES; POLYETHYLENE GLYCOLS; PYRIMIDINES; REMISSION INDUCTION; SYNDROME;

EID: 58149352976     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2008.05.013     Document Type: Article

References (8)

1. de Lange J., van den Akker H.P., and van de Berg H. Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104 (2007) 603-615
2. Stickler G.B., Hughes W., and Houchin P. Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): A survey. Genet Med 3 (2001) 192-196
3. Druker B.J., Tamura S., Buchdunger E., et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2 (1996) 561-566
4. Dewar A.L., Farrugia A.N., Condina M.R., et al. Imatinib as a potential antiresorptive therapy for bone disease. Blood 107 (2006) 4334-4337
5. Fitter S., Dewar A.L., Kostakis P., et al. Long-term imatinib therapy promotes bone formation in CML patients. Blood 111 (2008) 2538-2547
6. Vered M., Buchner A., and Dayan D. Giant cell granuloma of the jawbones- a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factor. J Oral Pathol Med 35 (2006) 613-619
7. de Lange J., van den Akker H.P., van den Berg H., Richel D.J., and Gortzak R.A. Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of two cases. Int J Oral Maxillofac Surg 35 (2006) 865-869
8. Collins A. Experience with anti-angiogenic therapy of giant cell granuloma of the facial bones. Ann R Australas Coll Dent Surg 15 (2000) 170-175